P. Rubis

T. Stompór, W. Sułowicz, M. Kostkiewicz, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Myocardial Viability Detected by Myocardial Contrast Echocardiography—Prognostic Value in Patients after Myocardial Infarction

M. Kostkiewicz, W. Tracz, P. Podolec, 2010, Echocardiography.

Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated Cardiomyopathy

R. Banys, M. Krupiński, P. Podolec, 2021, Cells.

The patient with heart failure in the face of the coronavirus disease 2019 pandemic: an expert opinion of the Heart Failure Working Group of the Polish Cardiac Society

M. Lelonek, J. Nessler, E. Jankowska, 2020, Kardiologia Polska.

Clinical Utility and Validation of the Krakow DCM Risk Score—A Prognostic Model Dedicated to Dilated Cardiomyopathy

E. Dziewięcka, S. Wiśniowska-Śmiałek, P. Rubis, 2022, Journal of personalized medicine.

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model

P. Podolec, E. Dziewięcka, S. Wiśniowska-Śmiałek, 2020, ESC heart failure.

Expert opinion of the Heart Failure Working Group of the Polish Cardiac Society on the use of dapagliflozin in the treatment of heart failure with reduced ejection fraction.

P. Ponikowski, M. Lelonek, J. Gumprecht, 2021, Kardiologia polska.

Impact of progressive aortic regurgitation on outcomes after left ventricular assist device implantation

L. Lund, F. Ruschitzka, S. Grundmann, 2022, Heart and Vessels.

Update on myocarditis – review (RCD code: III-6A.1)

P. Podolec, P. Rubis, 2014 .

Comparison of 12-month kinetics of serum markers of fibrosis between treatment with angiotensin receptor neprilysin inhibitor (ARNI) and angiotensin converting enzyme inhibitor (ACE-I) in patients with heart failure with reduced ejection fraction.

P. Podolec, E. Dziewięcka, S. Wiśniowska-Śmiałek, 2020, Polish archives of internal medicine.

Prognostic value of fibrosis-related markers in dilated cardiomyopathy: A link between osteopontin and cardiovascular events.

P. Podolec, A. Kozanecki, E. Dziewięcka, 2018, Advances in medical sciences.

The burden of atrial fibrillation and its prognostic value in patients with dilated cardiomyopathy.

M. Kostkiewicz, P. Podolec, E. Dziewięcka, 2019, Kardiologia polska.

Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy.

P. Wołkow, L. Khachatryan, J. Totoń-Żurańska, 2020, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies

L. Tavazzi, J. Čelutkienė, P. Seferovic, 2018, European heart journal.

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

L. Tavazzi, M. Tendera, L. Calò, 2020, ESC heart failure.

Left ventricular hypertrophy: what lies beneath?

P. Rubis, 2019, Polish archives of internal medicine.

Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis

P. Michałek, M. Kostkiewicz, P. Podolec, 2020, Cardiology journal.

Mitral regurgitation severity dynamic during acute decompensated heart failure treatment

M. Hołda, P. Rubis, M. Konieczyńska, 2021, The International Journal of Cardiovascular Imaging.

First experience with sodium-glucose co-transporter 2 inhibitors in Polish patients with cardiovascular diseases.

M. Kostkiewicz, P. Podolec, E. Dziewięcka, 2020, Cardiology journal.

12‐month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new‐onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis

M. Kostkiewicz, P. Podolec, S. Wiśniowska-Śmiałek, 2017, Cytokine.

The Relationship between Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy

P. Banys, M. Krupiński, M. Kostkiewicz, 2022, Journal of personalized medicine.

The Prognostic Value of 99mTc-HMPAO-Labeled Leucocyte SPECT/CT in Cardiac Device-Related Infective Endocarditis.

M. Kostkiewicz, P. Podolec, B. Małecka, 2020, JACC. Cardiovascular imaging.

Sacubitril/valsartan for heart failure with reduced ejection fraction: A first real-life observational study in Poland.

M. Lelonek, A. Pawlak, S. Wiśniowska-Śmiałek, 2021, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy

P. Wołkow, J. Totoń-Żurańska, P. Podolec, 2019, Archives of medical science : AMS.

Heart structure and function in patients with generalized autoimmune diseases: echocardiography with tissue Doppler study

J. Musial, M. Kostkiewicz, P. Podolec, 2011, Acta cardiologica.

Eosinophilic myocarditis: Gardia lamblia infestation and Garcinia cambogia. Coincidence or causality? (RCD code: III‑1B.1.o)

P. Pieniążek, K. Dzierwa, P. Rubis, 2016 .

Complete recovery of a patient with cardiogenic shock due to parvovirus B19 fulminant myocarditis after treatment with extracorporeal membrane oxygenation and intravenous immunoglobulin.

S. Pankuweit, A. Gackowski, B. Kapelak, 2015, Polskie Archiwum Medycyny Wewnetrznej.

Cardiac implantable electronic devices with a defibrillator component and all‐cause mortality in left ventricular assist device carriers: results from the PCHF‐VAD registry

L. Lund, M. Metra, F. Ruschitzka, 2019, European journal of heart failure.

Safety profile of end-stage heart failure patients implanted with left ventricular assist devices. Krakow two-year observational all-comers study on left ventricular assist device recipients.

J. Nessler, P. Podolec, A. Gackowski, 2018, Kardiologia polska.

To what extent does prior antimicrobial therapy affect the diagnostic performance of radiolabeled leukocyte scintigraphy in infective endocarditis?

M. Kostkiewicz, P. Podolec, B. Małecka, 2022, Journal of Nuclear Cardiology.

Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF‐VAD registry

L. Lund, F. Ruschitzka, S. Grundmann, 2022, European journal of heart failure.

Hemangioma of the left ventricle (RCD code: VI-1B.4)

M. Kostkiewicz, P. Podolec, B. Kapelak, 2017 .

Comparison of two European models estimating risk of sudden cardiac death in hypertrophic cardiomyopathy

L. Khachatryan, P. Podolec, S. Wiśniowska-Śmiałek, 2017, Acta cardiologica.

Overlap cardiomyopathy – coexistence of hypertrophic and restrictive cardiomyopathy phenotypes in one patient (RCD code: III-2A.1)

P. Podolec, S. Wiśniowska-Śmiałek, P. Rubis, 2014 .

Cardiac amyloidosis — state-of-the-art diagnosis and emerging therapies

M. Kostkiewicz, P. Podolec, P. Rubis, 2020 .

Severe course of dilated cardiomyopathy associated with Duchenne muscular dystrophy (RCD code: III‑1A.3a)

P. Podolec, S. Wiśniowska-Śmiałek, P. Rubis, 2014 .

Impact of progressive aortic regurgitation on outcomes after left ventricular assist device implantation

L. Lund, F. Ruschitzka, S. Grundmann, 2022, Heart and Vessels.

Amyloid cardiomyopathy – the true burden, current approach to diagnosis and treatment (RCD code III‐3A.1, III‐3A.2)

M. Kostkiewicz, P. Podolec, P. Rubis, 2020 .

Angiotensin receptor neprilysin inhibitor treatment is safe and potentially efficacious in end‑stage hypertrophic cardiomyopathy.

M. Kostkiewicz, P. Podolec, S. Wiśniowska-Śmiałek, 2017, Polish archives of internal medicine.

L. Lund, F. Ruschitzka, S. Grundmann, 2022, ESC heart failure.

Low-normal systolic function and hypertrophic cardiomyopathy

P. Rubis, 2023, Heart.

Right ventricular morphology and function is not related with microRNAs and fibrosis markers in dilated cardiomyopathy.

P. Wołkow, J. Totoń-Żurańska, P. Podolec, 2013, Cardiology journal.

The prognostic role of exercise echocardiography in heart failure.

P. Podolec, G. Kopeć, P. Rubis, 2011, Kardiologia polska.

Identification of a variant hotspot in MYBPC3 and of a novel CSRP3 autosomal recessive alteration in a cohort of Polish cases affected by hypertrophic cardiomyopathy.

I. Bottillo, P. Grammatico, L. Laino, 2020, Polish archives of internal medicine.

The dynamic assessment of right‐ventricular function and its relation to exercise capacity in heart failure

W. Tracz, P. Podolec, G. Kopeć, 2010, European journal of heart failure.

Usefulness of the Evaluation of Isovolumic and Ejection Phase Myocardial Signals during Stress Echocardiography in Predicting Exercise Capacity in Heart Failure Patients

W. Tracz, P. Podolec, G. Kopeć, 2009, Echocardiography.

Hypertrophic cardiomyopathy or hereditary hemochromatosis? (RCD code: III‑2B.3.o)

M. Kostkiewicz, P. Podolec, S. Wiśniowska-Śmiałek, 2016 .

Relations between circulating microRNAs (miR-21, miR-26, miR-29, miR-30 and miR-133a), extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy.

P. Wołkow, J. Totoń-Żurańska, P. Podolec, 2017, International journal of cardiology.

Assessment of resting perfusion defect in patients with acute myocardial infarction: comparison of myocardial contrast echocardiography with contrast-enhanced magnetic resonance imaging.

M. Kostkiewicz, W. Tracz, P. Podolec, 2009, Kardiologia polska.

Clinical classification of rare cardiac arrhythmogenic and conduction disorders, and rare arrhythmias.

J. Brugada, A. Baranchuk, P. Kukla, 2019, Polish archives of internal medicine.

Atherosclerosis progression affects the relationship between endothelial function and aortic stiffness.

W. Tracz, P. Podolec, K. Żmudka, 2009, Atherosclerosis.

Usefulness of the evaluation of left ventricular diastolic function changes during stress echocardiography in predicting exercise capacity in patients with ischemic heart failure.

W. Tracz, P. Podolec, G. Kopeć, 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Arterial stiffness in adult patients after coarctation of aorta repair and with bicuspid aortic valve

K. Salapa, P. Podolec, G. Kopeć, 2018, Acta cardiologica.

Different biochemical profile of stable and decompensated systolic heart failure patients due to ischemic or dilated cardiomyopathy hospitalized in the tertiary cardiology center (RCD code: III-1)

L. Khachatryan, P. Podolec, P. Rubis, 2014 .

Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy

L. Khachatryan, P. Podolec, A. Kozanecki, 2016, Inflammation Research.

Trans-endocardial delivery of progenitor cells to compromised myocardium using the “needle technique”and risk of myocardial injury

P. Musialek, P. Rubis, L. Tekieli, 2022, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

The role of 99mTc-HMPAO-labelled white blood cell scintigraphy in the diagnosis of cardiac device-related infective endocarditis.

M. Kostkiewicz, P. Podolec, B. Małecka, 2020, European heart journal cardiovascular Imaging.

Advances in Molecular Imaging in Infective Endocarditis

M. Kostkiewicz, P. Podolec, A. Ząbek, 2023, Vaccines.